The Use of Galantamine and CDP-Choline to Treat Adults With Schizophrenia - Contacts and Locations

The Use of Galantamine and CDP-Choline to Treat Adults With Schizophrenia (STAR-1)

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00509067

Contacts


Contact: Stephanie M Rosse, BS	202-745-8000 ext 6172	Stephanie.Rosse@va.gov

Contact: Barbara L. Schwartz, PhD	202-745-8000 ext 7206	Barbara.Schwartz@va.gov

Locations


United States, District of Columbia
	Washington Veterans Affairs Medical Center	Recruiting
	Washington, District of Columbia, United States, 20422
	Contact: Stephanie M. Rosse, BS 202-745-8000 ext 6172 Stephanie.Rosse@va.gov
	Contact: Barbara L. Schwartz, PhD 202-745-8000 ext 7206 Barbara.Schwartz@va.gov
	Principal Investigator: Stephen I. Deutsch, PhD, MD
	Sub-Investigator: Richard B. Rosse, MD
	Sub-Investigator: Nina Schooler, PhD
	Sub-Investigator: Barbara L. Schwartz, PhD

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

Investigators


Principal Investigator:	Stephen I. Deutsch, PhD, MD	Washington Veterans Affairs Medical Center